A randomized controlled trial of dihydroartemisinin-piperaquine, artesunate-mefloquine and extended artemether-lumefantrine treatments for malaria in pregnancy on the Thailand-Myanmar border

BACKGROUND: Artemisinin and artemisinin-based combination therapy (ACT) partner drug resistance in Plasmodium falciparum have spread across the Greater Mekong Subregion compromising antimalarial treatment. The current 3-day artemether-lumefantrine regimen has been associated with high treatment fail...

Descripción completa

Detalles Bibliográficos
Autores principales: Saito, Makoto, Carrara, Verena I., Gilder, Mary Ellen, Min, Aung Myat, Tun, Nay Win, Pimanpanarak, Mupawjay, Viladpai-nguen, Jacher, Paw, Moo Kho, Haohankhunnatham, Warat, Konghahong, Kamonchanok, Phyo, Aung Pyae, Chu, Cindy, Turner, Claudia, Lee, Sue J., Duanguppama, Jureeporn, Imwong, Mallika, Bancone, Germana, Proux, Stephane, Singhasivanon, Pratap, White, Nicholas J., Nosten, François, McGready, Rose
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191049/
https://www.ncbi.nlm.nih.gov/pubmed/34107963
http://dx.doi.org/10.1186/s12916-021-02002-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191049/
https://www.ncbi.nlm.nih.gov/pubmed/34107963
http://dx.doi.org/10.1186/s12916-021-02002-8

Ejemplares similares